Your browser doesn't support javascript.
loading
The circadian rhythm key gene ARNTL2: a novel prognostic biomarker for immunosuppressive tumor microenvironment identification and immunotherapy outcome prediction in human cancers.
Wu, Gujie; Ren, Hefei; Hu, Qin; Ma, Huiyun; Chen, Hongyu; Zhou, Lin; Xu, Kun; Ding, Liang.
Afiliação
  • Wu G; Department of Respiratory medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
  • Ren H; Department of Laboratory Medicine, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Hu Q; Department of Respiratory medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
  • Ma H; Department of Respiratory medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
  • Chen H; Department of Respiratory medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
  • Zhou L; Department of Respiratory medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
  • Xu K; Department of Chemotherapy, Jiangsu Cancer Hospital, Nanjing Medical University, Nanjing, China.
  • Ding L; Department of Respiratory medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
Front Immunol ; 14: 1115809, 2023.
Article em En | MEDLINE | ID: mdl-37275880
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Fatores de Transcrição ARNTL / Microambiente Tumoral / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Fatores de Transcrição ARNTL / Microambiente Tumoral / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article